Related Experiment Video
Updated: May 19, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Parvovirus B19 myocarditis causes significant morbidity and mortality in children
Kimberly M Molina1, Xiomara Garcia, Susan W Denfield
1Section of Pediatric Cardiology, Primary Children's Medical Center, University of Utah, 100 N Mario Capecchi Drive, Suite 1500, Salt Lake City, UT 84113, USA. kimberly.molina@imail.org
Insights
Parvovirus B19 (PVB19) causes severe pediatric myocarditis, leading to high rates of heart failure, transplantation, and death. Early ST changes and higher LVEDD z-scores indicate poorer outcomes in children with PVB19 myocarditis.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Myocardial Health
Background:
- Parvovirus B19 (PVB19) is a common cause of viral myocarditis, but pediatric data are limited.
- Unlike other viruses, PVB19 targets coronary endothelium, causing myocardial ischemia and dysfunction.
Purpose of the Study:
- To investigate outcomes of pediatric patients with polymerase chain reaction (PCR)-verified PVB19 myocarditis.
- To identify factors associated with transplant-free survival and circulatory collapse in pediatric PVB19 myocarditis.
Main Methods:
- Retrospective review of 19 pediatric patients (6 months to 15 years) with PCR-verified PVB19 myocarditis.
- Data collected from January 2005 to August 2008 at two children's hospitals.
- Primary endpoints: transplant-free survival and circulatory collapse (death, mechanical support, or transplantation).
Main Results:
- All patients presented with ventricular dysfunction requiring inotropic support (median ejection fraction 24%).
- Elevated B-type natriuretic peptide and troponin I levels were common.
- 32% of patients achieved transplant-free survival; 5 experienced full recovery.
Conclusions:
- Pediatric PVB19 myocarditis is associated with significant mortality and morbidity.
- Mechanical support and transplantation are often required due to persistent cardiac dysfunction.
- Fewer ST changes on ECG and lower admission LVEDD z-scores correlated with better transplant-free survival.
Abstract:
Although parvovirus B19 (PVB19) currently is the most common cause of viral myocarditis, limited pediatric data exist. Whereas other viruses infect cardiomyocytes, PVB19 targets coronary endothelium, leading to myocardial ischemia and dysfunction. A retrospective review investigated patients with polymerase chain reaction (PCR)-verified PVB19 myocarditis at Texas Children's Hospital and Arkansas Children's Hospital (January 2005 to August 2008). The primary end points of the study were transplant-free survival and circulatory collapse (death, mechanical support, or transplantation). For the 19 patients identified (age, 6 months to 15 years), the most common presenting symptoms were respiratory and gastrointestinal. At admission, all the patients demonstrated ventricular dysfunction requiring inotropic support (median ejection fraction, 24 %; median left ventricle end-diastolic diameter [LVEDD] z-score, 4.6). Whereas T-wave abnormalities were common, ST elevation was evident in five patients (two died and three required transplantation). Serum B-type natrietic peptide was elevated in all 12 patients tested (range, 348-8,058 pg/ml), and troponin I was high in 7 of 9 patients (range, 0.04-14.5 ng/ml). Of the 15 patients with circulatory collapse, nine received mechanical support, eight underwent successful transplantation, and five died. Only six patients (32 %) experienced transplant-free survival, and five patients had full recovery of function at discharge. In the transplant-free survival group, ST changes on presenting electrocardiography were less likely (p = 0.03), and the admission LVEDD z-score tended to be lower (3.3 vs 5.6; p = 0.08). In children, PVB19 myocarditis causes significant mortality and morbidity. Although mechanical intervention can support patients in the initial stage of decompensated heart failure, patients with PVB19 myocarditis often demonstrate persistent dysfunction requiring medical therapy and transplantation.
Related Concept Videos
Cytomegalovirus Disease
Myocarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Diphtheria
Myocarditis IV: Nursing Management